OCC-WCC 2024 | WCC固定劑量聯合療法和複方藥片論壇：2030年前心血管死亡率降低的新希望
*僅供醫學專業人士閱讀參考
在快速變化的醫學領域，疾病的防治始終是研究的熱點和難點。第十八屆東方心臟病學會議（The 18th Oriental Congress of Cardiology，OCC 2024）與世界心臟病學大會（World Congress of Cardiology，WCC 2024）的召開，為我們提供了一個絕佳的契機，來深度挖掘和探討複方藥片在心血管疾病治療中的潛力。
屆時，全球頂尖的醫學專家們將齊聚固定劑量聯合療法和複方藥片論壇，圍繞複方藥片在心血管疾病治療中的應用進行深入交流。他們將共同探討複方藥片在降低心血管疾病死亡率方面的實際效果和未來發展前景，為心血管疾病的防治提供新的思路和方法。
In the rapidly evolving field of medicine, the prevention and treatment of cardiovascular diseases remain a hot topic and a difficult challenge. The convening of the 18th Oriental Congress of Cardiology (OCC 2024) and the World Congress of Cardiology (WCC 2024) presents an excellent opportunity for us to delve deeply into and explore the potential of combination drug tablets in the treatment of cardiovascular diseases.
At that time, top medical experts worldwide will gather to engage in intensive discussions surrounding the application of combination drug tablets in cardiovascular disease treatment. They will jointly deliberate on the practical effects and future prospects of these tablets in reducing cardiovascular disease mortality, providing novel ideas and methods for the prevention and treatment of cardiovascular diseases.
論壇名稱：WCC-固定劑量聯合療法和複方藥片論壇
論壇時間：2024年6月27日 星期四
論壇地點：上海國際會議中心明珠廳
論壇壇主：美國哈佛大學公共衛生學院Thomas Gaziano教授；
南京醫科大學第一附屬醫院李新立教授
Forum Name：WCC-Fixed-dose combination therapies and polypill Forum
Forum Date: Thursday ,June 27, 2024 ；
Forum Venue: Pearl Hall，Shanghai International Conference Centre
Forum Chairs:
Professor Thomas Gaziano, Harvard Medical School;
Professor Li Xinli, The First Affiliated Hospital of Nanjing Medical University
Thomas Gaziano
李新立教授
治療依從性的衡量
A measure of treatment adherence
平衡心血管藥物治療的依從性和臨床慣性對於心血管疾病的管理至關重要。固定劑量聯合療法和複方藥品透過多藥聯合，能夠減少藥物種類和劑量，簡化治療方案，同時有助於減少藥物間的相互作用，進一步提升患者的依從性和長期治療效果。
布宜諾斯艾利斯大學 Vilma Irazola教授將重點圍繞治療依從性和臨床慣性之間的平衡，幫助臨床醫生和患者共同實現心血管疾病藥物治療的最優解決方案。
Balancing compliance and clinical inertia with cardiovascular drug therapy is essential for the management of cardiovascular diseases. Fixed-dose combination therapy and combination drugs can reduce the type and dose of drugs, simplify the treatment plan, and help to reduce the interaction between drugs, and further improve patient compliance and long-term treatment effect.
Professor Vilma Irazola from University of Buenos Aires will focus on the balance between treatment compliance and clinical inertia, helping clinicians and patients to achieve the optimal solution for cardiovascular diseases.
二級預防的實證
The evidence of secondary prevention
固定劑量聯合療法和複方藥片在心血管疾病的二級預防中扮演著核心角色。前者透過精確組合多種藥物，為患者提供全面而有效的治療，以控制心血管疾病的風險因素；而後者則將不同藥物整合為單一製劑，簡化治療流程，提高患者的用藥依從性。
西班牙國家心血管研究中心José Maria Castellano Vázquez教授將仔細剖析二級預防心血管死亡率降低的證據，展示固定劑量聯合療法和複方藥片在降低心血管疾病死亡率方面的顯著效果，為制定更為科學、合理的治療方案提供了有力的支援。
Fixed-dose combination therapy and polypills play a pivotal role in the secondary prevention of cardiovascular diseases. The former provides comprehensive and effective treatment for patients by precisely combining multiple drugs to control risk factors for cardiovascular diseases, while the latter integrates different drugs into a single formulation, simplifying the treatment process and improving patients medication adherence.
Professor José Maria Castellano Vázquez from Spanish National Centre for Cardiovascular Research will carefully analyze the evidence of reduced cardiovascular mortality in secondary prevention, demonstrating the significant effects of fixed-dose combination therapy and polypills in reducing cardiovascular mortality. This provides strong support for developing more scientific and rational treatment plans.
政策實施的挑戰
Challenges in policy implementation
在推廣固定劑量聯合療法和複方藥片以降低心血管疾病死亡率的過程中，政策實施面臨著多重壁壘。倫敦衛生與熱帶醫學學院Adrianna Murphy教授將深入探討這些挑戰，揭示諸如藥物審批流程的複雜性、醫療資源分配不均以及患者用藥意識和經濟能力差異等關鍵障礙，為理解並解決這些壁壘提供重要的見解和策略。
In the process of promoting fixed-dose combination therapy and polypills to reduce cardiovascular disease mortality, policy implementation faces multiple barriers. Professor Adrianna Murphy from London School of Hygiene and Tropical Medicine will delve deeply into these challenges, revealing key obstacles such as the complexity of drug approval processes, uneven distribution of medical resources, and differences in patients medication awareness and economic capabilities. She will provide important insights and strategies for understanding and addressing these barriers.
心臟治療的新策略
New Strategies for Heart Treatment
在美洲地區，心血管疾病長期以來一直是危害人們健康的首要元凶。隨著醫學研究的不斷深化和醫療技術的飛速發展，心臟治療領域也在不斷革新和突破。近年來，複方藥丸作為一種綜合治療心血管疾病的創新手段，逐漸嶄露頭角，並引起了廣泛的關注。
泛美衛生組織Pedro Orduñez教授將深入剖析並介紹在美洲心臟治療中納入複方藥丸的重要性與可行性,這不僅將為美洲地區心血管疾病的防治提供新的思路和方法，還將為全球心血管健康領域的研究人員和臨床醫生提供寶貴的參考和借鑑。
In the Americas, cardiovascular diseases have long been the leading cause of health hazards. With the continuous deepening of medical research and rapid development of medical technology, the field of heart treatment is constantly innovating and breaking new ground. In recent years, polypills, as an innovative means of comprehensive treatment for cardiovascular diseases, have gradually emerged and attracted widespread attention.
Professor Pedro Orduñez from Pan American Health Organization will delve deeply into and introduce the importance and feasibility of incorporating polypills into heart treatment in the Americas. This will not only provide new ideas and methods for the prevention and treatment of cardiovascular diseases in the Americas, but also offer valuable references and insights for researchers and clinicians in the global cardiovascular health field.
我們滿懷熱忱地期待WCC-固定劑量聯合療法和複方藥片論壇這場學術盛宴。論壇將匯聚業界精英，共同探討複方藥片在心血管健康領域的巨大潛力，以及它們如何在未來十年內顯著降低心血管疾病的死亡率。我們堅信，這次論壇將為心血管健康事業帶來新的啟示和動力，共同邁向一個更加健康、更加繁榮的未來。
We eagerly anticipate the academic extravaganza of the WCC Fixed-Dose Combination Therapy and Polypills Forum. The forum will gather industry elites to jointly explore the immense potential of polypills in the field of cardiovascular health, as well as how they can significantly reduce cardiovascular disease mortality in the next decade. We firmly believe that this forum will bring new insights and momentum to the cardiovascular health industry, moving towards a healthier and more prosperous future together!
歡迎註冊
會議時間：2024年6月27-30日
會議地點：上海國際會議中心
註冊官網：www.occmd.org
Conference Dates：June 27-30, 2024
Conference Venue：Shanghai International Convention Center
Registration Website：www.occmd.org
更多心血管精彩內容
快來“醫生站網頁版”瞧一瞧
精彩資訊等你來
稽核：李新立 錢菊英 陸國平 徐亞偉
*"醫學界"力求所發表內容專業、可靠，但不對內容的準確性做出承諾；請相關各方在採用或以此作為決策依據時另行核查。